大型前庭神经鞘瘤采用计划性次全显微切除与立体定向放射外科的颅神经保留策略:荟萃分析及国际立体定向放射外科学会(ISRS)实践指南
该系统综述与荟萃分析纳入12项系列研究共677例大型前庭神经鞘瘤患者,评估计划性次全显微切除后对残留肿瘤行立体定向放射外科(SRS)的疗效。总体肿瘤控制率为89.9%(86.9-92.9%,p<0.001),显微术后即刻面神经功能保留率为88.0%(82.7-93.3%,p<0.001),末次随访时升至94.4%(91.4-97.4%,p<0.001)。国际立体定向放射外科学会(ISRS)据此提出临床实践共识推荐。
要点
- 计划性次全切除后SRS的总体肿瘤控制率为89.9%(86.9-92.9%)。
- 显微术后即刻面神经功能保留率为88.0%(82.7-93.3%),末次随访升至94.4%(91.4-97.4%)。
- 显微术后即刻耳蜗功能保留率为58.8%(33.2-84.4%),末次随访降至57.4%(33-81.8%)。
核心结论
- 采用颅神经保留策略,即计划性次全显微切除后对残留肿瘤行SRS,可获得高肿瘤控制率及令人高度满意的面神经与耳蜗功能保留结局。
- 代表国际立体定向放射外科学会(ISRS)的临床实践共识推荐亦一并提出。
研究设计与样本
- 系统综述与荟萃分析,检索Medline和Embase数据库,采用PRISMA方法,检索截止日期为2023年6月1日,纳入报告大型前庭神经鞘瘤接受计划性次全切除后SRS结局的文献。
- 共纳入12项系列研究,报告677例患者的治疗结局, crude outcomes采用加权随机效应模型合并。
主要发现
- 总体肿瘤控制率为89.9%(86.9-92.9%,p<0.001)。
- SRS后肿瘤稳定为43.9%(19.9-68%,p<0.001),肿瘤缩小为39.9%(57-74.2%,p=0.02)。
- 显微术后即刻面神经功能保留率为88.0%(82.7-93.3%,p<0.001),末次随访时改善至94.4%(91.4-97.4%,p<0.001)。
- 显微术后即刻耳蜗功能保留率为58.8%(33.2-84.4%,p<0.001),末次随访时降至57.4%(33-81.8%,p<0.001)。
关键数值与推荐
- 原文未报告具体的推荐条款或推荐等级。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Stereotactic radiosurgery (SRS) has become a standard of care for small- to medium- size vestibular schwannomas (VS), while the majority of patients with large VS still require microsurgical resection due to potential consequences of long tract and cranial nerve compression, intracranial hypertension or hydrocephalus. METHODS: We performed a systematic review and meta-analysis of the literature specific to planned subtotal resection for large VSs followed by SRS to the residual tumor to inform clinical practice guideline development. The Medline and Embase databases were used to apply the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) approach to search for manuscripts reporting outcomes for large VSs treated with this paradigm, with a search end date of June 1st 2023. Crude outcomes were pooled using weighted random effects. RESULTS: 12 series met inclusion criteria reporting on treatment outcomes for 677 patients. Overall tumor control was 89.9% (86.9-92.9%, p < 0.001), with tumor stability observed in 43.9% (19.9-68%, p < 0.001) and tumor reduction in 39.9% (57-74.2%, p = 0.02) post-SRS. Facial nerve functional preservation immediately after microsurgery was 88.0% (82.7-93.3%, p < 0.001), improving to 94.4% (91.4-97.4%, p < 0.001) at last follow-up. Cochlear functional preservation immediately after microsurgery was 58.8% (33.2-84.4%, p < 0.001), decreasing to 57.4% (33-81.8%, p < 0.001) at last follow-up. CONCLUSIONS: A cranial nerve sparing approach with planned subtotal microsurgical resection and SRS to the residual tumor achieves high rates of tumor control with highly satisfactory outcome of facial and cochlear functional preservation. Clinical practice consensus recommendations on behalf of the International Stereotactic Radiosurgery Society (ISRS) are also presented.
引用
- Tuleasca C, Kotecha R, Sahgal A, et al. Large vestibular schwannoma treated using a cranial nerve sparing approach with planned subtotal microsurgical resection and stereotactic radiosurgery: meta-analysis and International Stereotactic Radiosurgery Society (ISRS) practice guidelines. J Neurooncol. 2025. PMID: 40172792. doi:10.1007/s11060-025-04990-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。